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Timed Sleep
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*Department of Neuroscience and †Department of Ecology and Evolutionary Biology, Brown University, Providence,
Rhode Island 02912
ABSTRACT In Caenorhabditis elegans, Notch signaling regulates developmentally timed sleep during the
transition from L4 larval stage to adulthood (L4/A) . To identify core sleep pathways and to ﬁnd genes acting
downstream of Notch signaling, we undertook the ﬁrst genome-wide, classical genetic screen focused on C.
elegans developmentally timed sleep. To increase screen efﬁciency, we ﬁrst looked for mutations that
suppressed inappropriate anachronistic sleep in adult hsp::osm-11 animals overexpressing the Notch col-
igand OSM-11 after heat shock. We retained suppressor lines that also had defects in L4/A developmentally
timed sleep, without heat shock overexpression of the Notch coligand. Sixteen suppressor lines with defects
in developmentally timed sleep were identiﬁed. One line carried a new allele of goa-1; loss of GOA-1 Gao
decreased C. elegans sleep. Another line carried a new allele of gpb-2, encoding a Gb5 protein; Gb5
proteins have not been previously implicated in sleep. In other scenarios, Gb5 GPB-2 acts with regulators
of G protein signaling (RGS proteins) EAT-16 and EGL-10 to terminate either EGL-30 Gaq signaling or
GOA-1 Gao signaling, respectively. We found that loss of Gb5 GPB-2 or RGS EAT-16 decreased L4/A sleep.
By contrast, EGL-10 loss had no impact. Instead, loss of RGS-1 and RGS-2 increased sleep. Combined, our
results suggest that, in the context of L4/A sleep, GPB-2 predominantly acts with EAT-16 RGS to inhibit EGL-
30 Gaq signaling. These results conﬁrm the importance of G protein signaling in sleep and demonstrate that










All animals sleep. The state of sleep in animals involves cessation of
locomotion, species-speciﬁcposture, and increasedarousal thresholdwith
slower behavioral response to environmental stimulation (Campbell and
Tobler 1984; Trojanowski and Raizen 2016). It is clear that sleep
involves coordinated changes in neuronal excitability; many chan-
nel subunits and signaling pathway components have been identi-
ﬁed as critical for sleep across species (Cirelli 2009; Sehgal and
Mignot 2011; Singh et al. 2014; Funato et al. 2016). However, con-
nections between these genes/pathways are often obscure. And, it is
still unclear how the state of sleep is achieved, what mechanisms
regulate the need for sleep, and how animals seamlessly transition
between the sleep and wake states.
Conserved genes regulate sleep across species, including Caeno-
rhabditis elegans. Numerous studies have established that conserved
genes identiﬁed in other species also regulate sleep in C. elegans, and
vice versa (Singh et al. 2014; Kucherenko et al. 2016; Trojanowski and
Raizen 2016). C. elegans developmentally timed sleep occurs at the end
of each larval stage during lethargus, which is coincident with shedding
of the cuticle (ecdysis) (Raizen et al. 2008). The timing of lethargus and
ecdysis is regulated, in part, by the C. elegans Period ortholog, LIN-42
(Monsalve et al. 2011). Other conserved components regulating sleep
include epidermal growth factor (Van Buskirk and Sternberg 2007),
Notch (Singh et al. 2011), protein kinase G (PKG) (Raizen et al. 2008),
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neurotransmitters (Singh et al. 2014), neuropeptides (Nelson et al.
2013; Turek et al. 2016), transcription factors (Turek et al. 2013), and
G proteins (Singh et al. 2014; Schwarz and Bringmann 2013).
Classical forward genetic screens identify genes and pathways
based on phenotypes of mutant animals. Forward genetic screens
are unbiased, leverage the strengths of model organisms, and were
critical in the dissection of circadian rhythm pathways (Hardin 2011),
among others. We suggest that forward genetic screens will also be
important for identifying critical genes and pathways required for
sleep. Forward genetic screens focused on sleep have been carried
out in ﬂies and in mice (Hardin 2011; Sehgal and Mignot 2011;
Funato et al. 2016). But, none have been focused on endogenous sleep
in C. elegans. Thus far, identiﬁcation of genes required for sleep in
C. elegans has been achieved by testing existing mutant strains (Turek
et al. 2013), examining candidate genes based on work in other spe-
cies (Singh et al. 2014), or focusing only on stress-induced sleep
(Iannacone et al. 2017).
Here, we describe the ﬁrst classical forward genetic screen under-
taken to identify genes regulating C. elegans developmentally timed
sleep. We identiﬁed multiple mutagenized lines with defects in devel-
opmentally timed sleep and, thus far, have identiﬁed new alleles in two
genes, goa-1 and gpb-2, that are required for developmentally timed
sleep. These, and additional results presented here, conﬁrm the impor-
tance of G protein signaling pathways in sleep.
MATERIALS AND METHODS
C. elegans culture and strain information
C. eleganswere cultured on standard Nematode GrowthMedia (NGM)
seeded withOP50 Escherichia coli and grown at 25. Strains used in this
study are shown in Table 1. Strains and alleles identiﬁed in the screen
are listed in Supplemental Material, Table S2 in File S2.
Ethyl methanesulfonate (EMS) mutagenesis and F2
lines setup
L4 larvae of the strain HA1133 (rtIs26 [hsp::osm-11;elt-2::gfp]) were
mutagenized with 47 mM EMS using standard methods (Brenner
1974). Three P0 adult animals were allowed to lay eggs for 3 hr in a
culture dish, yielding around 20–30 eggs. F1 generation adults were
removed when 100 eggs were laid. Sixteen F2 animals were singled
from each culture dish and their F3 generation progeny were examined
in the primary screen.
Primary screen: suppression of hsp::osm-11 adult
anachronistic sleep (Ans)
Plates for F2 lines with adult F3 progeny were sealed with Paraﬁlm
(Bemis Company, Inc.) and heat shocked for 75 min, ﬂoating agar side
down in a 33.5water bath. Paraﬁlm was removed and animals allowed
to recover in a 20 incubator for 50min. Suppression of Ans defects was
scored in the next 20-min interval (between 50 and 70min after the end
of heat shock). To score Ans, plate lids were kept closed to avoid waking
the animals, and plates were placed on the dissection scope agar side up,
due to condensation on the inner surface of the plate lid. Only young
adult animals were examined. Animals were scored as Ans if they did
not move spontaneously or pump for 5 sec (Figure 2A); either pharyn-
geal pumping or spontaneous locomotion was sufﬁcient to score an
animal as nonAns. We retained lines with 30% or less Ans animals,
examining up to 10 total young adults in each line. For lines passing this
initial test, two adults were singled for rescreening in subsequent gen-
erations. If multiple nonAns lines were identiﬁed from the same P0,
then only one nonAns line was retained after secondary screen.
Secondary screen: Multi-Worm Tracker (MWT)
assessment of L4/A sleep
TheMWT assays were undertaken on plates freshly seeded with 100ml
of OP50 culture spread into a thin lawn and dried in a fume hood with
the lid open for 60 min. Thirty “black dot” L4, substage L4.6 a la (Mok
et al. 2015) L4 animals, which are about to start lethargus, were picked
onto each assay plate and allowed to rest for 1 hr. Locomotion of the
population was tracked for 10 min using the MWT system (Swierczek
et al. 2011). Since theMWT requires an animal to move to start tracking,
we disturbed all animals on the dish by dropping the plates 5 cm, then
immediately initiated tracking. Metrics of fractional population sleep
(FPS), bout frequency (BF), and mean sleep bout duration (MSBD) were
calculated (see Figure 3A for deﬁnition of themetrics). The velocity of the
animals was determined as reported previously (Swierczek et al. 2011).
Sleep bouts were deﬁned as velocity of 0 mm/sec for at least 10 sec.
Metrics of FPS, BF, and MSBD were calculated with a custom Python
package (CMWT, https://github.com/Huiyan-Huang/CMWT).
Tertiary screen: microﬂuidic chamber-based assessment
of L4/A sleep
Amicroﬂuidic, chamber-based sleep systemwas adapted from previous
studies (Singh et al. 2011) and a detailed description of this protocol was
published recently (Huang et al. 2017). Brieﬂy, a static OP50 bacterial
culture, treated with kanamycin for at least a week, was resuspended at
an appropriate concentration in NGM (without agar), and applied to
6-chamber or 10-chamber microﬂuidic chips to facilitate loading ani-
mals and to serve as a food source. Mid-L4 stage animals, L4 substages
L4.3–L4.4 (Mok et al. 2015), were loaded into each chamber and cov-
ered with a glass coverslip, which was then sealed to the chip using
molten 2% agar. Images were recorded every 10 sec for 12 hr. Images
were analyzed using a MatLab script for image subtraction (Singh et al.
2011) and a custom Python script for calculating lethargus duration,
total sleep, and MSBD (https://github.com/Huiyan-Huang/C.-elegans-
sleep-analysis, branch: Calculate-sleep-metrics) (Huang et al. 2017).
Fractional quiescence was calculated as the rolling average over
10 min, corresponding to 60 adjacent images. The entry of lethargus
(Tstart) was deﬁned as the point at which the fractional quiescence
stayed above 0.1 for at least 20 min. The exit of lethargus (Tend) was
deﬁned as the point at which the fractional quiescence dropped to and
stayed below 0.1 for at least 20 min. Total sleep is deﬁned as the sum of
time in motionless sleep bouts (10 sec and up) during lethargus. Leth-
argus duration is the time between the entry and exit of lethargus.
MSBD is the average sleep bout length during lethargus (Figure 4A).
Note that for screening purposes, lethargus was deﬁned behaviorally
n Table 1 Strains used in the study
Strain names Genotypes
N2 Wild Type
HA1133 rtIs26 [hsp::osm-11;elt-2::gfp] I
HA2596 rt167rtIs26 [hsp::osm-11;elt-2::gfp] I (2·)
HA2469 rt186rtIs26 [hsp::osm-11;elt-2::gfp] I (2·)
DA541 gpb-2(ad541) I
JT603 gpb-2(sa603) I





MT8190 lin-15(n765) nIs51[egl-10(+), lin-15(+)] X
LX306 rgs-1(vs26) III; rgs-2(vs22) X
LX232 rgs-1(nr2017) III; rgs-2(vs17) X
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based on fractional quiescence appearing at least 1 hr after mid-L4
stage. Animals were selected based on vulval morphology. Vulval ever-
sion or ecdysis was not independently tracked.
Backcross and whole genome sequencing
Backcrossing of mutagenized lines was initiated using males from the
original unmutagenized strain, HA1133. F1 male progeny were crossed
to unmutagenized HA1133 females generated by fem-3 (RNAi). Eight
cross progenywere singled and the next generation was heat shocked to
induce Ans, as described above. Six nonAns young adult animals were
singled from each plate (total of 48) and their progeny were retested for
suppression of Ans. Four nonAns lines from different mothers were
retained and used to conﬁrm defects in endogenous developmentally
timed L4/A sleep using themicroﬂuidic chamber assay. If at least two of
these 2· backcrossed lines had defects in L4/A sleep, then two inde-
pendent backcrossed lines were used for whole genome resequencing. If
only one backcrossed line had defective endogenous L4/A sleep, then
backcrossing was reinitiated using the 2· backcrossed strain as de-
scribed above, to obtain one 4· backcrossed line for genome resequenc-
ing. DNA libraries were prepared using Illumina TruSeq DNA library
prep kit. Whole genome sequencing was done with Illumina HiSeq
2000 in the Genomics Facility at Brown University and sequencing
data were analyzed using CloudMap on Galaxy (Minevich et al.
2012). We focused on identiﬁcation of EMS-induced changes that
might induce stop codons, small exonic deletions that might induce
frame shifts, alterations in splice junctions, or missense amino acid
changes. Previously described alleles from the C. elegans Genetics Cen-
ter and other researchers were examined to determine if candidate
genes were required for normal sleep during L4/A lethargus.
Arousal threshold assessment using blue light
Arousal threshold assays were conducted as previously described (Chao
et al. 2004) with modiﬁcations. NGM agar plates were spread with a thin
100ml lawn ofOP50, then allowed to dry overnight (lid closed) or 20min
(lid open) in a fume hood. L4/A lethargus animals at L4 substage L4.7–
L4.9 (Mok et al. 2015) were picked onto assay plates and allowed to
recover for 15 min. During the assay, the plates remained unperturbed
with the lids off. A 5 mW, 405 nm laser pointer was used as stimulation,
occluded with a black paper except for a small hole0.5mm in diameter
in the center. A constant-current regulator set to 0.28 amperes was used
to power the laser light to achieve an intensity of100–110 lux. Under a
dissection stereomicroscope, animals were located and stimulated with
themost intense portion of the laser beamover the head of the nematode.
Response latency for animals in both sleep bouts and motion bouts was
recorded. For animals in sleep bouts, a response was deﬁned as any
movement. For animals in motion bouts, only forward moving animals
were tested and a response was deﬁned as the initiation of backward
locomotion. Light intensity was between 95 and 120 lux and did not
deviate.30 lux over the course of the experiment. At least eight animals
per genotype and per condition (asleep or inmotion) were tested for each
trial. At least three independent trials were conducted. The experimenter
was blinded as to genotype.
Statistics
Statistical analysis was conducted using two-tailed Student’s t-test and
F-test for nonzero slope for Figure S2 in File S1.
Data availability
Strains are available upon request. Scripts used to analyze the data are
uploaded to https://github.com/Huiyan-Huang. Whole genome se-
quencing data have been uploaded to NCBI Sequence Read Archive
(#SUB2845268: SRR5811622-SRR5832). File S1 contains detailed de-
scriptions of all supplemental ﬁles.
RESULTS
Primary screen: suppression of hsp::osm-11 adult
anachronistic sleep after heat shock
To identify genes involved in sleep, we undertook a classical forward
genetic screen. To facilitate identiﬁcation of these genes, the screen ﬁrst
focused on identiﬁcation of mutant alleles that suppressed the ectopic,
anachronistic sleep (Ans) induced in adult C. elegans by transient over-
expression of the Notch coligand OSM-11 (Singh et al. 2011). After
recovery from heat shock, a large fraction of young adult hsp::osm-11
animals are immobile due to Ans, compared to similarly treated wild-
type animals (Figure 1A and Figure 2A). We assumed that decreased
function of genes acting downstream of the Notch ligand or genes re-
quired for sleep (core sleep genes) might be identiﬁed as suppressors of
Ans in a forward genetic screen (Figure 1B). Therefore, we mutagenized
hsp::osm-11 animals, established F2 lines, and screened heat shocked F3
adult progeny for suppression of the Ans phenotype in our primary
screen (Figure 1C). Control hsp::osm-11 animals showed 60% Ans under
screening conditions; we retained 292 mutant lines with 30% or less Ans
adults, considering these to be putative Ans suppressor lines (Figure 1B)
as their fractional Answas similar towild-type populations (insert, Figure
2B). Next, putative Ans suppressor lines were rescreened to eliminate
false positives. We randomly singled two adults from each Ans suppres-
sor line and rescreened sublines in next generation.Wewere able to retest
274 putative Ans suppressor lines (Figure 2C); 118 lines showed suppres-
sion of Ans in both sublines. When multiple Ans suppressor lines were
derived from the same P0 animal, it was possible that related lines might
carry the samemutation. To avoid duplication of effort in the next stages
of the screen, we randomly eliminated 38 lines and retained 79 indepen-
dent Ans suppressor lines for secondary screening (Figure 1C).
Secondary screen: Multi-Worm Tracker assessment of
L4/A population sleep (no heat shock)
This screen was undertaken to identify genes required for developmen-
tally timed sleep. We were uninterested in mutations that suppressed
OSM-11 overexpression-induced Ans due to perturbation of the heat
shock pathway or mutations that decreased expression from the hsp::
osm-11 transgene. Additionally, an unknown fraction of Ans might be
attributable to induction of stress-induced sleep (Hill et al. 2014). To
winnow the Ans suppressor lines and identify mutant alleles that affect
endogenous developmentally timed sleep, we examined L4/A sleep in
the Ans suppressor lines in the absence of heat shock. Conveniently,
without heat shock, the L4/A sleep of hsp::osm-11 animals is indistin-
guishable from wild-type animals (Figure 3C and Figure 4, B and C).
To rescreen expeditiously, we developed a population-based L4/A
fractional sleep assay as a secondary screen (Figure 3A). During L4/A
lethargus, sleep bouts constitute roughly 30% of lethargus (Figure 3B).
Mutations that decrease sleep often result in animals with less frequent,
fewer or shorter sleep bouts during lethargus; conversely, mutations
that increase sleep can havemore frequent, more, or longer sleep bouts.
We assumed that strains with dramatic differences in L4/A total sleep
could be identiﬁed by sampling a population of animals for a short
period of time during L4/A lethargus. We deﬁned a new metric of
“fractional population sleep” (FPS) as the fractional time a population
spends in sleep bouts during the time interval sampled. However,
sleep bouts are not evenly dispersed during lethargus. To maximize
sensitivity, we examined previously published mutant animals and
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chose to measure FPS at 1 hr after lethargus entry. A previously de-
scribed system that simultaneously tracks locomotion of multiple
animals on culture plates, called the Multi-Worm Tracker (MWT)
(Swierczek et al. 2011) was adapted for FPS measurement. To rescreen
Ans suppressor lines for defects in L4/A lethargus sleep, we selected
late-L4 stage animals based on vulval morphology andmeasured FPS at
1 hr into L4/A lethargus (Figure 3B). Each Ans suppressor line was
tested in three independent trials with 30–40 animals each trial, sam-
pling only 10 min of sleep for the population during L4/A lethargus.
Animalsofunusual size,posture,oruncoordinated locomotioncannot
be tracked accurately with theMWT system. ElevenAns suppressor lines
fell into this category andwere passed to the tertiary screen below,without
evaluation in the secondary screen. Population sleepwas examined for the
remaining 68 lines. In addition to FPS, we deﬁned additional population
sleep metrics for the secondary screen: bout frequency (BF) and mean
sleep bout duration (MSBD), as shown in Figure 3A. FPS and BF were
strongly correlated within each mutant line (Figure 3C); there was little
variation inMSBDacrossmutant lines (Table S1 in File S2).We used FPS
to select mutant lines for further analysis. Decreased Notch signaling can
lead to either less sleep or more sleep during L4/A lethargus. Animals
carrying strong loss-of-function alleles are easy to wake from sleep bouts
and spend less time sleeping during lethargus; animals with less severe
alleles are easy to wake, but they increase sleep quantity, presumably to
compensate for poor sleep quality (Singh et al. 2011). Accordingly, we
retained 21 Ans suppressor lines that had either decreased or increased
FPS for the tertiary screen, along with the 11 Ans suppressor lines that
could not be assayed in the MWT (Figure 1C and Figure 3C).
Tertiary screen: microﬂuidic chamber assessment of
L4/A sleep defects (no heat shock)
To conﬁrm that mutant alleles in the remaining 32mutant lines altered
developmentally timed sleep, we used a previously established micro-
ﬂuidic chamber-based system (Singh et al. 2011) to examine endoge-
nous L4/A sleep, without heat shock (Figure 4A). Individual late L4
animals were loaded into microﬂuidic chambers and images were cap-
tured every 10 sec for 12 hr, which encompasses the entire L4/A leth-
argus (Figure 3B). Previously described analysis programs were used to
detect movement and sleep, based on image subtraction. Lethargus
entry, exit, and sleep metrics were determined, including total sleep,
lethargus duration, and MSBD. At least 10 animals were examined for
each Ans suppressor line in the tertiary screen (see Figure 4A and
Materials andMethods for details). Sixteenmutant lines had signiﬁcant
sleep defects during L4/A lethargus, when compared to wild type and
hsp:osm-11 control animals (Figure 4, B and C and Table S2 in File S2).
Animals from some mutant lines sleep less than control animals; an-
imals sleep more in other lines.
Whole genome sequencing ﬁnds two causal genes for
sleep defects: goa-1 and gpb-2
We undertook further analysis of seven mutant lines with unequivocal
L4/A sleep defects. To decrease the number of nonpertinent, EMS-
induced nucleotide changes, we backcrossedmutant lines to the original
hsp::osm-11 strains and reisolated homozygous mutant animals, based
on suppression of Ans and L4/A sleep defects. For each line, genomic
DNA from either one 4· backcrossed line or two independent 2·
backcrossed lines was sequenced to identify candidate causal alleles.
We assumed that causal alleles would be homozygous in backcrossed
lines and unique to each line. After genome resequencing, roughly
10–20 homozygous, unique exonic changes were identiﬁed as candidate
alleles for eachmutant line. To identify causal alleles and corresponding
genes, we determined if L4/A sleep was perturbed by preexisting alleles
or RNAi knockdown of candidate genes. Animals expressing the SID-1
double-stranded RNA channel in neurons were used for RNAi feed-
ing studies. Using this approach, goa-1 and gpb-2 were successfully
Figure 1 Screening rationale and strategy. (A)
Heat shock-induced OSM-11 overexpression
drives anachronistic sleep (Ans) at all stages,
included in adult animals shown here. Each data
point represents % Ans animals for an individual
plate of animals. Trials were run independently on
at least three different days for each genotype/
treatment.  P , 0.001. (B) Genetic pathways pro-
moting sleep. OSM-11 expression activates Notch
pathway signaling and, consequently, activates
downstream core sleep pathways (e.g., egl-4 PKG)
to promote both anachronistic sleep in adult animals
and endogenous, developmentally timed L4/A
sleep. Other sleep pathways (e.g., lin-42) likely act
independently to activate core sleep pathways and
promote sleep. (C) Flow chart of the screen and
results. Two thousand one hundred and thirty-two
F2 lines were established and the F3 progeny were
screened for suppression of the Ans phenotype. Se-
venty-nine independent Ans suppressor lines were
retained and tested for defects in endogenous L4/A
lethargus sleep in population-based assays using a
Multi-Worm Tracker system. Detailed analysis of L4/
A lethargus sleep for 32 lines was carried out in
microﬂuidic chambers and 16 lines showed L4/A
sleep defects. Seven lines were backcrossed and
their genomic DNA was sequenced to ﬁnd causal
alleles. Genes whose loss of function results in sleep
defects were identiﬁed for two mutant lines and
were conﬁrmed using previously described alleles.
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identiﬁed for causal alleles rt167 and rt186, respectively. The pheno-
types of lines carrying rt167 and rt186 at each stage of the screen are
indicated in Figure 2 and Figure 4. Both suppressed Ans, reduced
population sleep in the MWT, and reduced total sleep in microﬂuidic
chamber assays.
rt167 is a missense mutation in goa-1, converting serine 253 to
leucine (S253L). Serine 253 is highly conserved across animal species
(Figure 5, A, B, and E) (Slep et al. 2008). Previous studies have estab-
lished that loss of Gao GOA-1 function leads to decreased sleep in
animals (Guo et al. 2011; Singh et al. 2014; Schwarz and Bringmann
2013); isolation of goa-1(rt167) conﬁrms the utility of screening strat-
egies outlined here. gpb-2(rt186) is a missense mutation converting a
highly conserved aspartic acid at position 362 to asparagine (D362N) in
the Gb5 protein GPB-2 (Figure 5, C and D) (Cheever et al. 2008). We
ascribed sleep defects to loss of gpb-2 function as animals carrying
reduced function alleles gpb-2(sa603) and gpb-2(ad541) (Robatzek
et al. 2001) had decreased L4/A sleep (Figure 5G). However, we realized
that due to the unique function of GPB-2, biased alleles might be a
potential issue (Porter et al. 2010 and see below). We also determined
that gpb-2 loss-of-function animals had reduced arousal thresholds
during L4/A sleep bouts (Figure S1 in File S1), consistent with defects
in sleep. Therefore, the ﬁrst genome-wide, forward genetic screen for
genes involved in developmentally timed sleep revealed a previously
unknown role for GPB-2 in sleep. Identifying two proteins involved in
G protein signaling, despite the relatively low number of mutagenized
lines screened, highlights the importance of this pathway and war-
ranted further investigation.
RGS proteins EAT-16, RGS-1, and RGS-2 are required
for normal L4/A sleep
InC. elegans, previous work suggested that GPB-2 directly binds to and
is required for the function of two regulator of G protein signaling
(RGS) proteins: EAT-16 and EGL-10 (van der Linden et al. 2001).
GPB-2 helps these RGS proteins activate the intrinsic GTPase activity
of Gaq EGL-30 and Gao GOA-1, respectively (Chase et al. 2001;
Robatzek et al. 2001). These Ga proteins play antagonistic roles in syn-
aptic release regulating locomotion and egg-laying. Since both EGL-30
andGOA-1 have been previously demonstrated to play antagonistic roles
in C. elegans sleep (Schwarz and Bringmann 2013; Singh et al. 2014), it
wasnot surprising thatGPB-2 loss also impactedC. elegans sleep.However,
considering the antagonistic roles of GOA-1 and EGL-30, loss of GPB-2
function theoretically could have resulted in no overall net impact on sleep
or resulted in poorly regulated sleep, with highly variable sleep quantity.
We consistently observed reduced sleep in gpb-2 loss-of-function animals,
suggesting a biased impact of G protein signaling on L4/A lethargus
sleep or a biased selection of alleles tested (Porter et al. 2010). Mutations
in GPB-2 could have two distinct effects: some reducing or eliminating all
GBP-2 functions, and others preferentially inactivating GPB-2/EAT-16
complex while leaving GPB-2/EGL-10 function relatively intact (Porter
et al. 2010). Based on egg-laying and locomotion phenotypes of the two
gpb-2 alleles tested here, sa607 reduces GPB-2 function while ad541 is
biased toward inactivating GPB-2/EAT-16 complex. To circumvent the
potential allele bias of gpb-2, we decided to determine the function of
EAT-16 and EGL-10 in sleep, respectively.
To ﬁrst conﬁrm the role of egl-30 in sleep, we examined animals
carrying egl-30 gain-of-function alleles (Figure 6A) and veriﬁed re-
duced L4/A sleep (Figure 6A). Consistent with this observation, two
loss-of-function alleles of eat-16 also resulted in decreased sleep, con-
sistent with previously described actions of these proteins (Figure 6B).
Unexpectedly, two independent loss-of-function alleles of egl-10 did
not lead to L4/A sleep defects in either total sleep, lethargus duration,
or mean sleep bout duration, despite our ﬁnding that overexpression of
EGL-10 in multi-copy arrays was sufﬁcient to decrease sleep (Figure 6,
C and D). These two results suggest that egl-10 is normally dispensable
Figure 2 Primary screen: suppression of hsp::osm-11 adult anachronistic
sleep. (A) Diagram of anachronistic sleep suppression primary screen.
After heat shock, suppression of Ans was assessed for each mutagenized
line. (B) Histogram of primary screen results. Two thousand one hundred
and thirty-two hsp::osm-11 lines were tested and plates with no more than
30% Ans adults were considered candidate Ans suppressor lines. Two
hundred and ninety-two lines (light gray bars) initially suppressed Ans.
These were retested in the next generation for suppression of Ans. (C)
118 lines, corresponding to 79 independent F2 lines, passed the rescreen
for Ans suppression. The average of two plates scored for each line is
shown for the rescreen. goa-1(rt167) and gpb-2(rt186) are indicated. Plates
containing heat shocked wild-type animals were used as controls during
the screen; Ans observed on control animal plates is shown in insets.
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in this paradigm; alternative RGS proteins may normally be required to
regulate GOA-1 function during L4/A lethargus and permit sleep.
Likely candidates for these alternative RGS proteins were RGS-1
and/or RGS-2. These two proteins act redundantly to inhibit
GOA-1 signaling and allow reinitiation of egg-laying after refeeding
post starvation (Dong et al. 2000). We found that animals lacking
both rgs-1 and rgs-2 had increased sleep, which is consistent with
their loss leading to a presumable increase in GOA-1 signaling
(Figure 6E). We conclude that, during lethargus, GPB-2 mainly
interacts with EAT-16 to attenuate EGL-30 signaling, while GOA-1
signaling is negatively regulated by RGS-1 and RGS-2. It remains un-
clear if EGL-10 plays a role in endogenous lethargus sleep, but EGL-30
Gaq signaling and GOA-1 Gao signaling are critical for normal L4/A
sleep, and their function is dependent on RGS-1, RGS-2, EAT-16, and
GPB-2 (Figure 6F).
DISCUSSION
Here we describe the ﬁrst classical, forward genetic screen for genes
involved in C. elegans developmentally timed sleep. We identiﬁed one
gene previously implicated in sleep (goa-1) and one gene previously not
implicated (gpb-2). Examination of loss-of-function alleles for G pro-
tein signaling pathway components revealed that GPB-2 likely acts with
EAT-16 to inhibit EGL-30 Gaq signaling in this paradigm. Moreover,
examination of other RGS proteins revealed that GOA-1 Gao signaling
is regulated by RGS-1 and RGS-2 during L4/A lethargus, rather than
EGL-10.
Starting with 2132 mutagenized F2 lines, we used primary, second-
ary, and tertiary screening strategies to identify 16 mutant lines with
defects in endogenous, developmentally timed L4/A sleep. Reﬂecting
back on our design of the screen, we appreciate the convenience of
basing the primary screen on suppression of ectopic anachronistic sleep
Figure 3 Secondary screen: Multi-Worm-Tracker (MWT)
assessment of endogenous L4/A sleep. (A) Diagram of
population sleep assay using MWT. A population of at
least 30 midlethargus, freely roaming L4/A animals were
tracked for 10 min using the MWT for each line. These
animals were not heat shocked. Population sleep was
measured using metrics deﬁned here. Fractional popula-
tion sleep (FPS) is the total time in sleep for all animals
divided by the total time tracked for all animals. Bout
frequency (BF) is the number of bouts (of at least 10 sec)
for all animals divided by the total time tracked for all
animals. Mean sleep bout duration (MSBD) is FPS divided
by BF, which is total time in sleep divided by number of
bouts. Each data point represents the mean of at least
two independent trials on different days. (B) During L4/A
lethargus, C. elegans cycles between sleep bouts and
motion bouts. The illustration indicates approximate time
of MWT population tracking (blue column) during L4/A
lethargus. (C) Plot of BF (y-axis) vs. FPS (x-axis) for all Ans
suppressor lines tested. Control strains are shown as cir-
cles; there is no signiﬁcant difference between wild-type
animals (green circles) and non-heat-shocked hsp::osm-
11 animals (blue circles). Ans suppressor lines are shown
as triangles; lines retained for tertiary screening are indi-
cated (outside pale gray boxes, black triangles). goa-
1(rt167) and gpb-2(rt186) are indicated.
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(Ans). This approach signiﬁcantly reduced the number of lines exam-
ined in secondary and tertiary screens for endogenous L4/A sleep de-
fects. We acknowledge that relying on suppression of Ans in the
primary screen means that only genes downstream of Notch signaling
and/or core sleep genes can be identiﬁed.
Having completed the screen, we reexamined the effectiveness of the
population-based MWT assay as a screening strategy to identify strains
with developmentally timed sleep defects. One measure of effectiveness
is the success rate in tertiary screening for lines passed from the MWT
secondary screen vs. lines that skipped the MWT. Of the 21 lines that
had population sleep defects in theMWT, only 11 showed sleep defects
in the microﬂuidic chamber assay: roughly a 50% success rate. Of the
11 lines that bypassed MWT secondary screening due to size, posture,
and/or locomotion defects, ﬁve had sleep defects: again, roughly a 50%
success rate. Two-sided Fisher’s exact test suggests that there was no
obvious beneﬁt from MWT (P. 0.9999). But, this comparison might
be ﬂawed as locomotion defects that cause tracking problems in MWT
might also affect sleep assessment. However, we do not generally ﬁnd
that locomotion defects preclude accurate sleep assessments in micro-
ﬂuidic chamber assays. Therefore, as an alternative strategy to retro-
spectively assess the utility of the MWT assay for sleep studies, we
examined the correlation between MWT results and microﬂuidic
chamber results for each mutant line. We plotted MWT FPS vs.micro-
ﬂuidic chamber total sleep; no signiﬁcant correlation was seen (R2 =
0.026, P = 0.48, Figure S2 in File S1). Admittedly, it is possible that
causal alleles were not homozygous during secondary screening, but
this seems an uncommon scenario. Overall, we do not recommend the
MWT population-based assays to assess L4/A sleep defects. Instead, we
strongly recommend using the established microﬂuidic chamber assay,
which we used here for tertiary screening.
Howmany C. elegans genes are important for L4/A lethargus sleep?
An earlier study estimated that roughly 15% of Drosophila genes af-
fected sleep (Harbison and Sehgal 2008). Here, we started with 2132 F2
mutagenized lines and yielded 16 mutant lines with endogenous sleep
Figure 4 Tertiary screen: microﬂuidic chamber sleep
assay. (A) Diagram of the microﬂuidic chamber assay.
Early- to mid-L4 animals were loaded into microﬂuidic
chambers and imaged every 10 sec for 12 hr (as in
Figure 3B). These animals were not heat shocked. Sleep
during lethargus was measured for each animal tested
using the metrics deﬁned previously and shown here.
Total sleep is the sum of time in sleep bouts during
L4/A lethargus. Lethargus duration is deﬁned as the
time between the appearance and cessation of fre-
quent sleep bouts. We did not determine if vulval ever-
sion or ecdysis timing was changed for Ans suppressor
lines. Mean sleep bout duration (MSDB) is the total
sleep divided by the total number of sleep bouts during
lethargus. (B) Plot of lethargus duration (y-axis) vs. total
time in L4/A sleep (x-axis) for all lines tested in the
tertiary screen. (C) Plot of MSBD (y-axis) vs. total time
in L4/A sleep (x-axis) for the same lines in B. Each data
point represents the mean of at least 10 animals from
each line/genotype. Control strains are shown as cir-
cles. There is no signiﬁcant difference between wild-
type (green circles) and hsp::osm-11 (blue circles) ani-
mals. Lines that passed the preceding MWT secondary
screen are shown as triangles; lines tested here that
bypassed the MWT secondary screen are shown as di-
amonds. Sixteen lines altered L4/A lethargus sleep and
were retained (outside pale gray boxes, black triangles,
or black diamonds). goa-1(rt167) and gpb-2(rt186) are
indicated.
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defects. For an F2 recessive screen of this design (50 mM EMS and
sparse screening of F2 plates), standard calculations suggest that a
homozygous loss-of-function allele for an average C. elegans gene will
be found once for every 5000 F2 lines examined (Brenner 1974;
Greenwald and Horvitz 1980; Shaham 2007). Based on our results,
one might suggest that the C. elegans genome has roughly 38 genes
that both suppress Ans and dramatically perturb L4/A lethargus sleep,
which would include Notch downstream target genes and core sleep
genes. This is likely a dramatic underestimate for several reasons. First,
we note that the ineffective secondary screen using the FPS/MWT likely
led us to discard many mutant lines carrying alleles that impact de-
velopmentally timed sleep, perhaps up to 50%. Considering this, the
genome likely contains .80 genes required for Ans whose loss also
dramatically alters endogenous sleep. Next, we note that our screen-
ing strategy focused on identifying alleles that cause dramatic sleep
defects; genes with more subtle defects or changes in lethargus tim-
ing would not be identiﬁed. Finally, we suggest that not all genes
involved in sleep will be required for Ans, which is induced by
Notch pathway activation. Based on these considerations, we con-
clude that a rational estimate of the number of genes required for
sleep in C. elegans cannot yet be made.
Here, we identiﬁed mutant strains that suppressed anachronistic,
adult sleep (Ans) in adult animals. Some suppressor strains decreased
totalL4/Asleep,whichseemscounterintuitive.Wesuggest threepossible
explanations. First, some strains may carry two pertinent mutations in
two different genes; onemutation that only decreases Ans sleep and one
that fortuitously increasesL4/Asleep.Althoughmanygenesare required
for sleep, this should be a rare occurrence. Second, a singlemutation in a
suppressor strain may decrease Ans sleep and increase L4/A sleep. But
genes whose perturbation simultaneously leads to both of these defects
have not been reported previously. Third, Ans strains may carry
mutations in genes whose perturbation makes sleep less restorative,
leading to compensatory increases in sleep quantity. Strong decrements
in Notch pathway signaling lead to decreased L4/A sleep and inappro-
priately low arousal thresholds only during L4/A sleep bouts. (These
animals sleep lessandare easy towake.)But,milderdecrements inNotch
pathway signaling lead to increased L4/A sleep and inappropriately low
arousal thresholds only during L4/A sleep bouts. A similar suite of
defects was seen in C. elegans with decreased Jnk pathway signaling
(Singh et al. 2011). It was suggested that inappropriate low arousal
thresholds signify poor sleep quality, which engages homeostatic path-
ways and results in compensatory increases in sleep quantity. Given
Figure 5 Identiﬁcation of goa-1 and gpb-2 al-
leles. (A) Diagram showing location of goa-
1(rt167) in the sixth exon of goa-1. (B) Alignment
of amino acids adjacent to goa-1(rt167) showing
cross-species conservation. (C) Diagram showing
location of gpb-2(rt186) in the last exon of gpb-2,
as well as preexisting loss-of-function alleles that
were examined herein. (D) Alignment of amino
acids adjacent to gpb-2(rt186) showing cross-
species conservation. (E) goa-1(rt167) animals
had reduced total sleep compared to control
hsp::osm-11 animals. None of these animals were
heat shocked. Results from 2· backcrossed ani-
mals shown. (F) gpb-2(rt186) animals had reduced
total sleep compared with control hsp::osm-11
animals. None of these animals were heat shocked.
Results from 2· backcrossed animals shown. (G)
Animals carrying preexisting gpb-2 alleles had de-
creased total sleep, compared with wild-type ani-
mals. Mean and SEM indicated, along with results
for individual animals for each genotype.  P ,
0.01,  P , 0.001 by Student’s t-test vs. control
or wild-type animals run in parallel in multiple trials.
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that (i) a third of the mutant strains had increased sleep, (ii) this
suite of defects has been observed for Notch pathway genes, and (iii)
the primary screen relied on suppression of a Notch pathway gain-
of-function defect, we conclude that Ans lines with increased L4/A
sleep likely carry mutations in Notch pathway genes or transcrip-
tional targets.
Theﬁrst geneswe identiﬁed in this screenwere goa-1 and gpb-2, both
G proteins. G protein pathways are well conserved and play diverse
Figure 6 GPB-2 and RGS-1/2 regu-
late Gaq EGL-30 and Gao GOA-1,
respectively, in L4/A lethargus sleep.
(A) egl-30(tg26) gain-of-function ani-
mals had dramatically decreased to-
tal sleep during L4/A lethargus in
microﬂuidic chamber assays, consis-
tent with a previous report. Severe or
complete loss of egl-30 causes paral-
ysis or lethality. (B) Loss of function in
the RGS protein EAT-16 led to de-
creased L4/A lethargus sleep, con-
sistent with EAT-16 loss leading to
increased EGL-30 Gaq activity. (C)
Loss of RGS protein EGL-10 function
had no impact on L4/A lethargus
sleep, suggesting that other RGS pro-
tein(s) regulate pertinent Gao GOA-1
activity. Only L4/A total sleep is
shown here, but lethargus duration
and sleep bouts duration were also
not affected (data not shown). (D)
Increasing EGL-10 RGS protein ac-
tivity, using a previously described
overexpression strain, was sufﬁcient
to decrease L4/A lethargus sleep.
(E) Simultaneous loss of both RGS-1
and RGS-2 (RGS-1/2) led to increased
sleep. Two previously described dou-
ble mutant strains were examined.
Increased sleep observed here is con-
sistent with RGS-1/2 loss leading to
increased GOA-1 Gao activity (due
to decreased GTP hydrolysis), which
would cause more sleep. Mean and
SEM indicated, along with results for
individual animals for each geno-
type.  P , 0.05,  P , 0.01, 
P , 0.001 by Student’s t-test vs.
control or wild-type animals run in
parallel in multiple trials. (F) G pro-
tein pathway signaling pertinent to
L4/A lethargus sleep. On the right
side of the illustration, Gb5 GPB-2
and RGS EAT-16 proteins normally
act together to increase EGL-30
Gaq GTP hydrolysis, which decreases
overall signaling via EGL-30. EGL-30
Gaq is normally wake-promoting; in-
creased EGL-30 or gain of function
drives less sleep. The identity of pu-
tative G protein receptor(s) that drive
EGL-30 signaling is unclear. On the
left side of the illustration, loss of
GOA-1 Gao decreases sleep, sug-
gesting that GOA-1 Gao and effectors are normally sleep-promoting. In other behavioral contexts, Gb5 GPB-2 and RGS EGL-10 proteins act together
to regulate GOA-1 Gao activity, but loss of EGL-10 had no impact on L4/A lethargus sleep. However, loss of both RGS-1 and RGS-2 function altered
sleep suggesting that at least one of these RGS proteins acts to increase GOA-1 Gao GTP hydrolysis, which would decrease overall signaling via GOA-1
and downstream effectors. The GPCR receptors that drive increased GOA-1 Gao activity are also unknown. The balance of the Gaq and Gao signaling is
a major factor in determining the quantity of sleep seen in L4/A lethargus.
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roles in signaling events across species. Overexpression of theDrosoph-
ila GOA-1 ortholog induces sleep, while decreasing Gao signaling by
RNAi leads to fragmented sleep (Guo et al. 2011). However, to our
knowledge, Gaq signaling has not been previously implicated in sleep
in species other than C. elegans (Schwarz and Bringmann 2013), while
Gb5 has not been implicated in sleep at all. Gb5 knockout mice are
developmentally impaired and have multiple neurologic abnormalities
including hyperactivity, whichmight lead to reduced sleep (Zhang et al.
2011). We suggest that the Gaq signaling and Gb5 activity are also
required for normal sleep in other animal species.
RGS proteins are important modulators of the G protein signaling
and are expressed at high levels in neuronal tissues (Ross and Wilkie
2000; Neubig and Siderovski 2002). There are.20 genes encoding RGS
proteins in mammals and 13 genes in C. elegans. RGS proteins accel-
erate the slow intrinsic hydrolysis rate of GTP to GDP by Ga proteins.
A recent study examined RGS-insensitive Gai2 knock-in mice, ﬁnding
that RGS and Gai2 protein activity modulates wakefulness, NREM
sleep, and REM sleep (Zhang et al. 2016). Although no speciﬁc RGS
proteins were tested in this study, other reports suggest that RGS pro-
teins are involved in sleep and circadian rhythm regulation. The ex-
pression of RGS16 is circadian and is critical for the time-dependent
activation of intracellular cyclic AMP signaling in the suprachiasmatic
nucleus (SCN), a critical circadian center regulating behavioral rhythms
(Doi et al. 2011). There is also evidence that RGS4 and RGS2 protein
levels respond to melatonin signaling; protein levels peak during the
middle of the night and decline to basal levels during the day (Dupre
et al. 2011; Matsuo et al. 2013). A large-scale human GWAS study
identiﬁed a locus near RGS16, an established circadian gene, as asso-
ciated with self-reported early wakefulness (Hu et al. 2016). Moreover,
tumor necrosis factor may induce central nervous system dysfunction,
including lethargy, by up-regulation of RGS7 (Benzing et al. 1999).
EGL-10 and EAT-16 are the C. elegans orthologs of RGS7, and human
Gb5 speciﬁcally binds RGS6, RGS7, RGS9, and RGS11 (Witherow and
Slepak 2004). Additional studies will be required to determine if RGS7
loss alters sleep in mammals by modulating Gao or Gaq signaling.
Classic genetic screens provide an unbiased strategy for identifying
genesplayingunsuspectedroles inanybiologicalprocess, if robustscreening
strategies can be established. Given the proven utility of this approach for
other behaviors and our relatively poor understanding of the mechanisms
underlying sleep despite decades of effort, we suggest that classical forward
genetic screens will provide novel insights into the conserved genes and
pathways important for sleep across the animal kingdom.
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